Trading and investing full time for personal account and consulting with a money manager firm with assets of over $55 Million. Worked on Wall Street for 18 years at two wirehouses and one boutique investment banking firm. Investment discipline includes taking advantage of Wall Street's tendency to act quickly in herds and overdoing it to the upside and downside, along with standard long term investing in companies with good management that exceed financial expectations. Small companies that have yet to be followed by research analysts and investment firms are of particular interest, as the potential for above average returns, often in a short period of time, exists. Trading strategies are employed when a sell off or a price spike attracts attention for a quick opportunity.
I look for undervalued companies, unique opportunities and search the internet for everything under the sun that might help me turn up something others may have missed. I still believe in companies that have experienced management, real products, a growing revenue base, and do the right thing by their investors. There are a few really good bets out there with high ceilings. Finding them is like navigating a minefield filled with imposters, sharks and grifters.
VFC is just a guy with an opinion. VFC's Stock House brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - the biotech, pharmaceutical and healthcare sectors. VFC's Stock House provides research, informational and opinion-based coverage of various companies and stocks in multiple sectors.
The information contained within the pages of VFC’s Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and devise their own entry and exit strategies. Do not Buy/Sell based solely on VFC's ideas or opinions.
The goal of VFC's Stock House is to 'call it like I see it' - while bringing new ideas, companies, and discussions to the eyes of investors and readers. This is supposed to be fun and new investors should not invest with the idea that this will 'pay the bills' or with the belief that a stock will just keep going up. DD is paramount, but so is sticking to pre-conceived entry and exit strategies and not letting emotional trading get in the way.
Goals must be realistic, if it sounds far fetched, then it probably is. Let the big boys eat the cake - the small investor is just trying to pick up some crumbs, and there's nothing wrong with that!
I am an an entrepreneur, trader and programmer based in Mainz, Germany. I studied economics, journalism and ethnology at the Jonannes Gutenberg University, Mainz. My experience with financial websites goes back to the late 1990s when I published a German language site (redboerse.de) focusing on emerging technology stocks. To me, work must be enjoyable.
"The mind is like a parachute. It doesn't work if it is not open." (Frank Zappa)
I’ve put a lot of thought into planning my personal finances, and you can gain the benefit of my insights through my posts here and on Thoughtsworththinking.net. Like most investors, I was shocked by the financial crisis that emerged in 2008, and I have found the impetuous and often contradictory opinions expressed by some professionals on markets and the economy to be largely unhelpful. I have come to the conclusion that many (but not all) commentators lack the objectivity and perspective to speak credibly about the future.
In addition to holding a Master’s degree from the London School of Economics, where I studied the relationship between politics and the world economy, I am certified as a Financial Risk Manager (FRM) by the Global Association of Risk Professionals (GARP). But I think my most important experience in writing for Seeking Alpha is the work I put into making my own financial decisions. I don’t expect or recommend that anyone accept my opinion as sacrosanct, but as one of many perspectives that can add value to a studied investment decision. My goal in every article or opinion I offer is to provide something—whether a fact or confluence of arguments—that you will not be able to find anywhere else, using the experience, perspective, and research capabilities I bring to the table.
The information I provide on this web site does not constitute professional investment advice, and should only be used in consonance with all available information, including the opinion of a professional adviser, to make an investment decision.
Please visit Thoughtsworththinking.net
I live in the metropolitan area of Washington, D.C.
Full Time Micro Cap Investor. Founder of MicroCapClub.com
Founded in 2011, MicroCapClub is an exclusive forum for experienced microcap investors focused on microcap companies (sub $300m market cap). MicroCapClub was created to be a platform for experienced microcap investors to share and discuss stock ideas. MicroCapClub’s mission is to foster the highest quality microcap investor Community, produce Educational content for investors, and promote better Leadership in the microcap arena.
The Burrill Report is written for everyone who wants to understand how biotechnology operates as a business. Each month the publication focuses on the health of the industry and the strategies that will be needed to be successful. It provides actionable market intelligence on the latest global developments and trends in the life sciences industry. Available monthly, subscribers also benefit from monthly and quarterly market financial and business statistics on:
- Public companies
- venture financings
- Project Runway – Follow the global life sciences companies filing for and completing their IPOs – and their post market performances
- Clinical Trials successes and failures
- M&A and Partnering deals
- Periodic country features on Canada, Europe and emerging countries such as China & India.
In addition, BR provides in-depth coverage on specific sectors of life sciences including: Personalized Medicine; Diagnostics, Medical Devices and Biogreentech (Ag-Bio and Biofuels/Bioenergy). Through weekly Burrill Indices, the progress and prospects of biotech companies by size, from small through to blue-chip are also tracked.
Visit: The Burrill Report to obtain your sample issue (http://www.burrillreport.com/)
Zacks.com brings the decades of study and stock picking expertise of Zacks Investment Research to individual investors. Now, you don't to be an investment bank or brokerage firm to get the professional power of Zacks' research. It's all available on Zacks.com. Learn more about Zacks' history and company below.